Genzyme R&D is affected big time, this was expected and rumored about for a while now. The number is in low sixties and will stay there. Strategic R&D took the biggest hit. Let's hope this is it. I am not sure if Sanofi is cutting staff in other... — read more
The acquisition by Sanofi is turning Genzyme into a big pharma culture. Things have changed recently and the cohesive nature of Genzyme has slowly started to disappear. I am concerned that the next round of layoffs will be massive as Sanofi is after... — read more
The best Genzyme are leaving or are forced to leave - too bad, used to be a great company
Sanofi has grand plans for us in 2014 - I know they will cut for sure, I am not sure how much though? Do you think the cuts will be massive?
GEN was acquired by Sanofi-aventis and should be removed from this board...